HC Deb 18 December 2003 vol 415 cc1004-5W
Tom Brake

To ask the Secretary of State for International Development if he will make a statement on shortages of(a) antisera (anti-snake venom) and (b) anti-cancer medicines in Iraq. [143935]

Hilary Benn

Assessments by the World Health Organisation (WHO) and the Iraqi Ministry of Health earlier in the autumn indicated that there are no major shortages of essential medical supplies in Iraq. There are however still reported shortages of some very specialised supplies including antisera (ie anti snake venom) and some anti-cancer medicines.

A great deal has already been achieved to re-establish drug systems in Iraq. The initial focus was, rightly, or securing adequate supplies of the most essential and most used medicines and vaccines. On 27 October, the Iraqi Ministry of Health estimated that 15,000 tons of pharmaceuticals and medical supplies had beer delivered in 150 days. However, new supply systems are not yet fully operational. Until these are in place, including comprehensive accounting and reporting processes to ensure that needs are identified before shortages arise, some problems will continue to occur.

Work is currently underway in the Iraqi Ministry of Health to develop a national drug formulary. This will enable improved sourcing of drugs and a new purchasing structure which will facilitate the arrival of some drugs which were almost non-existent under the old regime, including top-tier cancer drugs and other advanced pharmaceuticals. Work is also being done by the Ministry of Health, CPA and WHO to develop a complete overview of missing drugs and supplies. This is scheduled to finish in three months.

Forward to